Early Initiated Ambulance-delivered Levetiracetam and Headposition in Hyper-acute Stroke Trial

PHASE3RecruitingINTERVENTIONAL
Enrollment

2,423

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2029

Conditions
Suspected Stroke
Interventions
DRUG

Levetiracetam

Intervention group - to commence IV levetiracetam 500mg as a single bolus in the ambulance, and then to continue as levetiracetam 500mg bid orally after admission to hospital in those with confirmed acute stroke for the next 14 days (at least 7 days if either dead or discharged from hospital if earlier). They will also receive standard management of acute stroke, whether the final diagnosis is ischaemic or ICH

OTHER

Guide-recommended management

To receive stroke management according to standard local guidelines, but to avoid prophylactic use of an anti-seizure drug.

OTHER

The lying flat (0°) head position

Lie flat (0°) - in the ambulance as soon as possible until arrival at hospital.

OTHER

The sitting-up (≥30°) head position

Sit up(30-60°) - in the ambulance as soon as possible until arrival at hospital.

Trial Locations (2)

200123

RECRUITING

Shanghai East Hospital, Shanghai

234399

RECRUITING

Si County People's Hospital, Suzhou

All Listed Sponsors
lead

Shanghai East Hospital

OTHER